OPEXA Company Presentation
Opexa Therapeutics August Corporate Presentation
eHealth presentation at ENS-EFN Istanbul
Are electronically enabled delivery devices (EEDDs) the future?
Personalised Care
Team Finland Health 2.0 Pitching
Etablierte und zukünftige immunmodulatorische Medikamente bei MS Fokus Forschung 01.11.2014 Schweizer MS Gesellschaft Ilijas Jelcic.
The business environment in Gulf Co-operation Council countries
EBF Survey: Quality Systems in Macromolecule Analysis
Opexa therapeutics corporate presentation october 2014
HOLs: The New Payer Facilitator: How Health Outcomes Liaisons Navigate Health Care Reform and Create Value within the Industry
Health Care & Consumer Health Point-Blank-International-Credentials
